Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.51, n°3 - July-August 2019
Paru le :
01/08/2019
Article en page(s) :
210-297
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Beyond LSD: A broader psychedelic zeitgeist during the early to mid-20th century. Aday J.S., Bloesch E.K., Davoli C.C., p. 210-217.
- "Not for human consumption": A descriptive investigation into user characteristics, motives, and consequences associated with bath salt use. Zimmerman L., Kilwein T.M., Beyer D., Marks C., Looby A., p. 218-224.
- A first-in-man study with 4-fluoroamphetamine demonstrates it produces a mild psychedelic state. Kuypers K.P.C., De Sousa Fernandes Perna E.B., Theunissen E.L., Toennes S.W., Mason N.L., Hutten N., et al., p. 225-235.
- Comparing mental health across distinct groups of users of psychedelics, MDMA, psychostimulants, and cannabis. Rougemont-Bucking A., Jungaberle H., Scheidegger M., Merlo M.C.G., Grazioli V.S., Daeppen J.B., et al., p. 236-246.
- Nightlife and drug use in Tbilisi, Georgia: Results of an exploratory qualitative study. Beselia A., Kirtadze I., Otiashvili D., p. 247-253.
- Dorsolateral prefrontal cortex impairment in methoxetamine-induced psychosis: An (18)F-FDG PET/CT case study. Moccia L., Tofani A., Mazza M., Covino M., Martinotti G., Schifano F., et al., p. 254-259.
- Age of initiation and patterns of use among people who inject drugs welcomed in harm reduction facilities in France from 2006 to 2015. Janssen E., Shah J., Néfau T., Cadet-Taïrou A., p. 260-271.
- Barriers to buprenorphine expansion in Ohio: A time-elapsed qualitative study. Molfenter T., Fitzgerald M., Jacobson N., McCarty D., Quanbeck A., Zehner M., p. 272-279.
- A randomized controlled trial of brief cognitive behavioral therapy for regular methamphetamine use in methadone treatment. Alammehrjerdi Z., Briggs N.E., Biglarian A., Mokri A., Dolan K., p. 280-289.
- Prevalence and correlates of lifetime alcohol use among adult urban populations in Iran: A knowledge, attitude, and practice study. Mehrabi M., Hajebi A., Mohebbi E., Baneshi M.R., Khodadost M., Haghdoost A.A., et al., p. 290-297.
- Beyond LSD: A broader psychedelic zeitgeist during the early to mid-20th century. Aday J.S., Bloesch E.K., Davoli C.C., p. 210-217.
- "Not for human consumption": A descriptive investigation into user characteristics, motives, and consequences associated with bath salt use. Zimmerman L., Kilwein T.M., Beyer D., Marks C., Looby A., p. 218-224.
- A first-in-man study with 4-fluoroamphetamine demonstrates it produces a mild psychedelic state. Kuypers K.P.C., De Sousa Fernandes Perna E.B., Theunissen E.L., Toennes S.W., Mason N.L., Hutten N., et al., p. 225-235.
- Comparing mental health across distinct groups of users of psychedelics, MDMA, psychostimulants, and cannabis. Rougemont-Bucking A., Jungaberle H., Scheidegger M., Merlo M.C.G., Grazioli V.S., Daeppen J.B., et al., p. 236-246.
- Nightlife and drug use in Tbilisi, Georgia: Results of an exploratory qualitative study. Beselia A., Kirtadze I., Otiashvili D., p. 247-253.
- Dorsolateral prefrontal cortex impairment in methoxetamine-induced psychosis: An (18)F-FDG PET/CT case study. Moccia L., Tofani A., Mazza M., Covino M., Martinotti G., Schifano F., et al., p. 254-259.
- Age of initiation and patterns of use among people who inject drugs welcomed in harm reduction facilities in France from 2006 to 2015. Janssen E., Shah J., Néfau T., Cadet-Taïrou A., p. 260-271.
- Barriers to buprenorphine expansion in Ohio: A time-elapsed qualitative study. Molfenter T., Fitzgerald M., Jacobson N., McCarty D., Quanbeck A., Zehner M., p. 272-279.
- A randomized controlled trial of brief cognitive behavioral therapy for regular methamphetamine use in methadone treatment. Alammehrjerdi Z., Briggs N.E., Biglarian A., Mokri A., Dolan K., p. 280-289.
- Prevalence and correlates of lifetime alcohol use among adult urban populations in Iran: A knowledge, attitude, and practice study. Mehrabi M., Hajebi A., Mohebbi E., Baneshi M.R., Khodadost M., Haghdoost A.A., et al., p. 290-297.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
E. JANSSEN ;
J. SHAH ;
T. NÉFAU ;
A. CADET-TAÏROU
|
2019
Dans Journal of Psychoactive Drugs (Vol.51, n°3, July-August 2019) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.51, n°3, July-August 2019) Article : Périodique
This exploratory analysis of time-series cross-sectional data provides insights on trends in age at first injection among people who inject drugs in France, and on associations with recent risky injecting behaviors. Data were collected from a na[...]
A. ROUGEMONT-BUCKING ;
H. JUNGABERLE ;
M. SCHEIDEGGER ;
M. C. G. MERLO ;
V. S. GRAZIOLI ;
J. B. DAEPPEN ;
G. GMEL ;
J. STUDER
|
2019
Dans Journal of Psychoactive Drugs (Vol.51, n°3, July-August 2019) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.51, n°3, July-August 2019) Article : Périodique
Differences in mental health (MH) of users of distinct psychoactive substances have been shown. Both substance use (SU) and MH in users are influenced by stressful life events. This study compared MH parameters in distinct groups of substance us[...]